Cyclerion Therapeutics (CYCN) Total Non-Current Liabilities (2019)
Cyclerion Therapeutics (CYCN) posted Total Non-Current Liabilities of $17.5 million for Q1 2019.
Powered by 
Analysis
Cyclerion Therapeutics (CYCN) Total Non-Current Liabilities (2019) Analysis & Trends
Cyclerion Therapeutics has reported Total Non-Current Liabilities for 1 years, with the latest figure at $17.5 million in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.38 Bn | 192.39 Bn | 7.24 Bn | 81.11 Bn |
| 2 | Gilead Sciences | 180.22 Bn | 177.04 Bn | 6.22 Bn | 36.04 Bn |
| 3 | Vertex Pharmaceuticals | 131.28 Bn | 123.42 Bn | 2.84 Bn | 5.92 Bn |
| 4 | Regeneron Pharmaceuticals | 81.96 Bn | 73.97 Bn | 3.93 Bn | 7.74 Bn |
| 5 | Argenx Se | 60.49 Bn | 55.30 Bn | 1.37 Bn | 40.00 Mn |
| 6 | Moderna | 53.90 Bn | 48.76 Bn | 52.00 Mn | 3.92 Bn |
| 7 | Alnylam Pharmaceuticals | 33.41 Bn | 30.11 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 12.42 Bn |
| 9 | Roivant Sciences | 29.08 Bn | 29.08 Bn | 1.16 Mn | 378.37 Mn |
| 10 | Cyclerion Therapeutics | 15.70 Mn | 12.46 Mn | - | - |